ATP Life Science Ventures, L.P.

Q1 2020 13F Holdings Report, Stock Holdings

Signature - Title
Seth L. Harrison - Director of the General Partner
Location
New York, NY
Holdings as of
March 31, 2020
Value $
$499M
Num holdings
2
Date filed
5/6/2020, 01:27 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q4 2019 - Feb 3, 2020
Next filing
Q2 2020 - Jul 10, 2020
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q1 compared to 2019 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Seth L. Harrison Director of the General Partner New York, New York 5/6/2020

Other Included Managers (1):

Num Name Location File Number
1 ATP III GP, Ltd. New York, NY 028-19730